Detection, quantitation and classification of RAS proteins in bo

Details Detection, quantitation and classification of RAS proteins in bo Detection, quantitation and classification of RAS proteins in bo

1993-06-17

1995-08-22

Saunders, David

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

435 74, 435 794, 436578, 436548, 436813, G01N 33573, G01N 33574, G01N 33577

Patent

active

054439566

ABSTRACT:
Detection, quantitation and classification of ras p21 proteins in body fluids, tissues, or cells is described. Specifically, this disclosure concerns detecting and quantitating normal and mutated ras p21s from normal subjects, subjects suspected of having preneoplastic disease or subjects known or suspected of having neoplastic (cancer) disease. This invention also concerns the detection and quantitation of the ras p21 proteins into the three families of ras proteins designated Ha, Ki and N in body fluids and tissues.

REFERENCES:
patent: 4228237 (1980-10-01), Hevey et al.
patent: 4504585 (1985-03-01), Reynolds
patent: 4535058 (1985-08-01), Weinberg et al.
patent: 4568640 (1986-02-01), Rubin
patent: 4690890 (1987-09-01), Loor et al.
patent: 4699877 (1987-10-01), Cline et al.
patent: 4725550 (1988-02-01), Perucho et al.
patent: 4762706 (1988-08-01), McCormick et al.
patent: 4786718 (1988-01-01), Weinberg et al.
patent: 4798787 (1989-01-01), McCormick et al.
patent: 4820631 (1989-04-01), Lacal et al.
patent: 4871838 (1989-10-01), Bos et al.
patent: 4898932 (1990-02-01), Carney
patent: 4957859 (1990-09-01), Bizub et al.
patent: 5015571 (1991-05-01), Niman et al.
patent: 5028527 (1991-07-01), Carney
patent: 5081230 (1992-01-01), Carney
patent: 5084380 (1992-01-01), Carney
patent: 5112737 (1992-05-01), Carney
Caruso et al., Int. J. Cancer, pp. 587-595, vol. 38 (1986).
Hand et al., Biochem. Biophys. Acta. 908(2):131-142 (1987).
Haand et al. JNCI 79(1):59-66 (1987).
Niman et al., Clin. Lab. Med. (US), 6(1):181-196 (Mar. 1986).
Niman et al., Proc. Natl. Acad. Sci. USA, pp. 7924-7928, vol. 82 (Dec. 1985).
Ohuchi et al., Can. Res. 47(5):1413-1420 (1987).
Ohuchi et al., Can. Res., pp. 2511-2519, vol. 46 (May 1986).
CA 106:174296y, pp. 550, vol. 106 (1987).
Andreff et al., Blood, pp. 676-681, vol. 87, No.3 (Mar. 1986).
Bizub et al., Oncogene, pp. 131-142, vol. 1 (1987).
Bos et al., Nature, pp. 726-730, vol. 315, (Jun. 27, 1985).
Carney et al., 78th Ann. Mtg. at Amer. Assn. for Can. Res., May 20-23, 1987.
Carney et al., UCLA Symposia, Jan. 20-Feb. 15, 1986, Steamboat Springs, Colorado; Alan N. Liss, Inc., NY Jour. Cell. Bio., Suppl. 10A (1986).
Carney et al., Fifth Ann. Congress for Hybridoma Res., Jan. 26-29, 1986, Balti., MD; Hybridoma 5(1).
Carney et al., Lab. Invest. 54:10A, Jan. 1986.
Carney et al., Lab. Invest. 58 (1988).
Carney et al., J. Cell. Bio., pp. 207-214, vol. 32 (1986).
Carney et al., Intl. Acad. Pathol., Mar. 1987; Lab Invest. 56(1)11A. abstract No. 59.
Carney et al., Intl. Acad. Path., Mar. 1987; Lab invest. 569(1)11A. abstract No. 60.
Carney et al., Third Ann. Mtg. on Oncogenes, Frederick, MD (1987).
Carney et al., Monoclonal Antibodies & Cancer Therapy, pp. 565-572. (1985).
Carney et al., 69th Ann. Mtg. FASEB (Apr. 1985).
Carney et al., Apr. 1986 Mtg. FASEB.
Carney et al., PNAS (USA), pp. 7485-7489, vol. 83 (Oct. 1986).
Carney et al., UCLA Symp. Mol. Cell. Biol. New. Ser., pp. 565-572, vol. 27 (1985); CA vol. 104(1986), No. 166570B.
Carney et al., 20th Ann. Oak Ridge Conf. on Advanced Analytical Concepts for Clin. Labs (Apr. 1988).
Carney et al., Dupont Biotechnology Update , p. 16 (Apr. 1988).
Chang et al., Nature, pp. 479-483, vol. 297 (Jun. 10, 1982).
Clanton et al., Mol. Cell. Biol., pp. 3092-3097, vol. 7, No. 9 (1987).
Clark et al., Biochemica et Biophysica Acta, pp. 9-20, vol. 738 (1984).
Clark et al., PNAS (USA), pp. 5280-5284, vol. 82, No. 16 (Aug. 1985).
Cooper et al., Biochimica et Biophysica Acta, pp. 9-20, vol. 738 (1984).
Der et al., Cell, pp. 167-176, vol. 44 (Jan. 17, 1986).
Faramo et al., J. Mol. Appl. Genet, 2(2):173-180 (1983).
Feramisco et al., Nature (England), 314 (6012): 639-642 (Apr. 18-24, 1985).
Finkel et al., Cell. pp. 151-158, vol. 37 (May 1984).
Freedman et al., In Vitro Cellular Developmental Biology, pp. 621-624, vol. 22, No. 10 (Oct. 1986).
Furth et al., J. of Virology, pp. 294-304, vol. 43 No. 1 (Jul. 1982).
Gallick et al., PNAS, pp. 1795-1799, vol. 82, Mar. 1985.
Gambke et al., Nature, pp. 476-478, vol. 307, (Feb. 2, 1984).
Ghosh et al., J. Clin. Pathol. (England), pp. 428-434, vol. 39, No. 4 (Apr. 1986).
Gibbs et al., PNAS (USA), pp. 5704-5708, vol. 81 (Sep. 1984).
Hamer et al., 72nd Ann, Mtg. FASEB, May 1-5, 1988, Las Vegas, Nev.
Hamer et al., Amer. Commer. & Indus. Conf. & Expo in Biotechnology, Apr, 27-May 1, 1986, Boston, MA.
Hand et al., PNAS pp. 5227-5231, vol. 81 (Aug. 1984).
Herlyn et al., J. Clin. Immun., pp. 135-140, vol. 2, No. 2. (1982).
Hirai et al., nature, pp. 430-432, vol. 327 (Jun. 4, 1987).
Ho et al., FASEB, vol. 46(3) (1987).
Kurzrock et al., Can. Res., pp. 1530-1534, vol. 46 (Mar. 1986).
Lacal et al., Mol. & Cell. Biol., pp. 1002-1009, vol. 6 No,4 (Apr. 1986).
Lee et al., Lab Invest. 56:42A (Mar. 1987).
Lefbvre et al., Lab. invest. 54:35a (Jan. 1986).
Liu et al., Nature, pp. 186-188, vol. 330 (Nov. 12, 1987).
Manne et al., PNAS (USA), pp. 376-380, vol. 82 (Jan. 1985).
McGrath et al., Nature, pp. 644-649, vol. 310, No. 23 (Aug. 1984).
Metzgar et al., Can. Res., pp. 601-608, vol. 42 (Feb. 1982).
Moore et al., Nature, pp. 733-734, vol. 327 (Jun 25, 1987).
Nishida et al., Biochem. Biophys. Res. Common. 146(1):247-252.
Nitta et al., Jpn. J. Res. (Gann). pp. 21-26, vol. 78 (Jan. 1987).
Papageorge et al., J. of Virol., pp. 509-519, vol. 519, vol. 44, No. 2 (Nov. 1982).
Parada et al., Nature, pp. 474-476, vol. 297 (Jun. 10, 1982).
Poe et al., J. Biol. Chem., pp. 3906-3909, vol. 260, No. 7 (Apr. 10, 1985).
Radosevich et al., Amer. Fed. Clin. Res., Sep. 1987, Chicago, Il.
Reddy et al., Nature, pp. 149-152, vol. 300 (Nov. 11, 1982).
Robinson et al., Br, J. Cancer, pp. 877-883, vol. 54 (1986).
Santos et al., Science, pp. 661-664, vol. 223 (Feb. 17, 1984).
Santos et al., Nature, pp. 343-344, vol. 298, (Jul. 22, 1982).
Schlom, Fifth Ann. Congress for Hybridoma Res., pp. 165-166, Jan. 26-29, 1986, Baltimore, Md.
Scolnick et al., PNAS (USA), pp. 5355-5359, vol. 76 (Oct. 1979).
Sevier et al., Clin. Chem., pp. 1797-1806, vol. 27, No. 11 (1981).
Shilo et al., Nature, pp. 607-609, vol. 289 (Feb. 12, 1981).
Shimizu et al., Nature, 304(5926), pp. 497-500 (1983).
Srivastava et al., Mol. & Cell. Biol., pp. 3316-3319, vol. 5, No. 22, (Nov. 1985).
Sweet et al., Nature, pp. 273-275, vol. 311 (Sep. 1984).
Tabin et al., Nature, pp. 143-149, vol. 300 (Nov. 11, 1982).
Tahara et al., Jpn. J. Can. Res. (Gann). pp. 517-522 (1986).
Tanaka et al., Can. Res., pp. 1465-1470, vol. 46 (Mar. 1986).
Tanaka et al., PNAS (USA), pp. 3400-3404, vol. 82 (May 1985).
Taparowsky et al., Banbury Report, 14:123-133) (1983); Chem. Abs, CA 100(1):1425n.
Taparowsky et al., Cell, pp. 581-586, vol. 34 (1983).
Thor et al., Nature, pp. 562-565, vol. 311 (Oct. 11, 1984).
Trimpe et al., Third Ann. Mtg on Oncogenes (1987).
Trimpe et al., Intl. Acad. Pathol., US & Can. Div., Feb. 29-Mar. 3, 1988, Wash. D.C.; Lab Invest. 58.
Wodnar-Filpowicz et al., Oncogene, pp. 457-461, vol. 1, No. 4 (1987).
Wolfe et al., Lab. Invest. 52:77a (1985).
Wong et al., Can. Res, pp. 6029-6033, vol. 46 (Dec. 1986).
Yuasa et al., Nature, pp. 775-779, vol. 303 (Jun. 30, 1983).
Zarbl et al., Nature, pp. 382-385, vol. 315 (May 30, 1985).
Bizub et al., Cancer Research 49:6425-6431 (Nov. 15, 1989).
Hamer et al., Hybridoma 9:573-587 (1990).
LaVecchio et al., Oncogene 5:1173-1178 (1990).
Kennel, J. Immunological Methods 55:172 (1982).
Dierks et al., Molec. Immunol. 23(4):403-411 (1986).
Jansson et al., Cancer, pp. 1329-1337, vol. 65 (Mar. 15, 1990).
Ng et al. "Plasma Detection of Activated Ras p21 Expression in MMTV/V-HA RAS Transgenic Mice" Abstract, Sixth Annual Meeting on Ocogenes, 1990.
Hamer et al., "Quantitation of HER-2/Neu Proteins in Breast and Ovarian Carcinomas" Abstract, Sixth Annual Meeting on Oncogenes, 1990.
Brandt-Rauf et al., Br. J. Industrial Medicine, 45:689-693 (1988).
Wolfman et al., J. Biol. Chem., pp. 10820-10827, vol. 224, No. 18 (1989).
Carney et al., Analysis of Ras Oncogene Proteins (p21) in Tumor Cells Using Flow Cytometry and Immunohistochemistry, 8th International Congress of Histochemistry and Cytochemistry, Aug. 1988.
Carney et al., Detection of Activated Ras Proteins in Human a

Affiliated with

Also associated with

Rating

Detection, quantitation and classification of RAS proteins in bo does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detection, quantitation and classification of RAS proteins in bo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection, quantitation and classification of RAS proteins in bo will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2141174